Cita APA (7th ed.)

Risueño, A., See, W., Bluemmert, I., de Botton, S., DiNardo, C., Fathi, A., . . . Hasan, M. (2024). Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. Elsevier.

Cita Chicago (17th ed.)

Risueño, A., et al. Somatic Gene Mutation Patterns and Burden Influence Outcomes with Enasidenib in Relapsed/refractory IDH2-mutated AML. Elsevier, 2024.

Cita MLA (9th ed.)

Risueño, A., et al. Somatic Gene Mutation Patterns and Burden Influence Outcomes with Enasidenib in Relapsed/refractory IDH2-mutated AML. Elsevier, 2024.

Atenció: Aquestes cites poden no estar 100% correctes.